Aster DM Healthcare Ltd's Q3FY25 Quarter Results
- 01 Feb 2025
Result Summary
- Aster DM Healthcare Ltd reported a 3.5% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a decline of 70.9%.
- Its expenses for the quarter were down by 0.7% QoQ and 72.6% YoY.
- The net profit decreased 39.1% QoQ and decreased 69.2% YoY.
- The earnings per share (EPS) of Aster DM Healthcare Ltd stood at 1.1 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 1082.80 | 1121.68 | 3718.56 | -3.5% | -70.9% |
Total Expenses | 953.61 | 960.43 | 3476.65 | -0.7% | -72.6% |
Profit Before Tax | 105.47 | 161.25 | 241.91 | -34.6% | -56.4% |
Tax | 37.49 | 52.89 | 24.24 | -29.1% | 54.7% |
Profit After Tax | 64.39 | 105.76 | 209.22 | -39.1% | -69.2% |
Earnings Per Share | 1.10 | 1.90 | 3.60 | -42.1% | -69.4% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Aster DM Healthcare Ltd is a prominent healthcare provider operating primarily in the Middle East and India. The company is involved in the management and operation of hospitals, clinics, and retail pharmacies. Aster DM Healthcare is known for its comprehensive service offerings that range from primary to quaternary care and its focus on providing high-quality healthcare services. Recent developments in the company include expansions into new regions and the introduction of advanced medical technologies to enhance service delivery. However, specific recent developments within the quarter are not provided in the given data.
Revenue
The total income for Aster DM Healthcare Ltd in Q3FY25 was ₹1082.80 crores, marking a decrease from ₹1121.68 crores in Q2FY25, which translates to a quarter-over-quarter (QoQ) decline of 3.5%. When compared to the same period in the previous year, Q3FY24, where the total income was ₹3718.56 crores, there is a significant year-over-year (YoY) decrease of 70.9%. This substantial YoY decline indicates a marked reduction in revenue streams over the past year.
Profitability
In Q3FY25, Aster DM Healthcare Ltd reported a Profit Before Tax (PBT) of ₹105.47 crores, which is a decrease from ₹161.25 crores in the previous quarter, representing a QoQ decline of 34.6%. When compared to the same quarter last year, with a PBT of ₹241.91 crores, there is a YoY decline of 56.4%. The Profit After Tax (PAT) for the current quarter stands at ₹64.39 crores, down from ₹105.76 crores in Q2FY25, reflecting a QoQ decrease of 39.1%. Compared to Q3FY24, the PAT has decreased by 69.2%. The Earnings Per Share (EPS) for the quarter is ₹1.10, lower than the previous quarter's ₹1.90 and significantly less than the ₹3.60 reported in Q3FY24, indicating a 42.1% QoQ and 69.4% YoY decline.
Operating Metrics
The total expenses for Aster DM Healthcare Ltd in Q3FY25 are reported at ₹953.61 crores, slightly down from ₹960.43 crores in Q2FY25, resulting in a QoQ decrease of 0.7%. When compared to Q3FY24, with expenses of ₹3476.65 crores, there is a YoY reduction of 72.6%. The tax expense for the current quarter is ₹37.49 crores, which is 29.1% lower than the previous quarter's ₹52.89 crores. However, when compared to Q3FY24, there is a notable increase of 54.7%. These figures reflect the company's financial management concerning its cost containment and tax strategy over the quarters.
